BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for the Amax Destiny Plus coagulation analyzers from Trinity Biotech

2006.12.19

Product group In-vitro diagnostics
Reference 02830/06

Corrective action of Trinity Biotech for Amax Destiny Plus coagulation analyzers because of erroneous results under certain circumstances. Customers were informed about the problem and how to avoid it.

Corrective action for the Amax Destiny Plus coagulation analyzers from Trinity Biotech , Download_VeroeffentlichtAm_EN PDF, 602KB, File does not meet accessibility standards